| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2009 | WO2009085177A1 Phenyl acetic acid derivatives as inflammation modulators |
| 07/09/2009 | WO2009085040A1 Protein kinase inhibitors |
| 07/09/2009 | WO2009084982A1 Use of organic dyes as an agent for treating oncological diseases |
| 07/09/2009 | WO2009084975A1 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 07/09/2009 | WO2009084974A1 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity |
| 07/09/2009 | WO2009084970A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | WO2009084835A2 Pharmaceutical composition for treatment and prevention of kidney diseases |
| 07/09/2009 | WO2009084834A2 Pharmaceutical composition for the treatment and prevention of cardiac disease |
| 07/09/2009 | WO2009084801A1 Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same |
| 07/09/2009 | WO2009084739A1 Method and pharmaceutical composition for treatment of cancer using bmp10 protein, |
| 07/09/2009 | WO2009084738A1 Method and pharmaceutical composition for treatment of cancer using bmp9 protein |
| 07/09/2009 | WO2009084737A1 Compound having activity to suppress degranulation and cytokine production and use thereof |
| 07/09/2009 | WO2009084732A1 Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084693A1 Antitumor agent |
| 07/09/2009 | WO2009084678A1 Oral cavity disintegrating tablet and method of producing the same |
| 07/09/2009 | WO2009084668A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method |
| 07/09/2009 | WO2009084621A1 Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same |
| 07/09/2009 | WO2009084614A1 Imidazole carbonyl compound |
| 07/09/2009 | WO2009084612A1 Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the eriocitrin-containing material |
| 07/09/2009 | WO2009084531A1 Monosebacate of pyrazole derivative |
| 07/09/2009 | WO2009084501A1 Sultam derivative |
| 07/09/2009 | WO2009084497A1 Methyl-substituted piperidine derivative |
| 07/09/2009 | WO2009084494A1 Antimicrobial agent for gram-positive bacteria |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084477A1 Preparation for external application to skin and cosmetic preparation |
| 07/09/2009 | WO2009084471A1 Emulsion preparation for external application to skin and cosmetic preparation |
| 07/09/2009 | WO2009084275A1 Composition for oral administration |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009084216A1 Oral powder and granular antitumor agent |
| 07/09/2009 | WO2009084200A1 External skin preparation for pimpled skin |
| 07/09/2009 | WO2009084044A1 Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
| 07/09/2009 | WO2009084041A2 Pharmaceutical compositions of dexibuprofen |
| 07/09/2009 | WO2009084040A1 Once a day formulation of angiotensin receptor blockers |
| 07/09/2009 | WO2009084021A2 Ophthalmic composition comprising a prostaglandin |
| 07/09/2009 | WO2009084017A2 Taste-masked orally disintegrating tablets of memantine hydrochloride |
| 07/09/2009 | WO2009084003A1 Pharmaceutical compositions of amlodipine and valsartan |
| 07/09/2009 | WO2009083972A2 Compositions and methods for enhancing the activity of podophyllotoxin |
| 07/09/2009 | WO2009083903A1 Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use |
| 07/09/2009 | WO2009083871A1 Combination between an isothiocyanate and levodopa for parkinson's disease treatment |
| 07/09/2009 | WO2009083802A2 Tea beverage and container |
| 07/09/2009 | WO2009083794A1 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence |
| 07/09/2009 | WO2009083793A1 Inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence |
| 07/09/2009 | WO2009083759A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | WO2009083739A1 Method of synthesis of bosentan, its polymorphic forms and its salts |
| 07/09/2009 | WO2009083643A2 Composition for treating sterile inflammation |
| 07/09/2009 | WO2009083614A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | WO2009083612A2 Flavonoid as means for the prophylaxis and treatment of neurodegenerative and other protein folding-aberration diseases |
| 07/09/2009 | WO2009083608A1 Quinazolines and related heterocyclic compounds, and their therapeutic use |
| 07/09/2009 | WO2009083581A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/09/2009 | WO2009083561A1 A slow-release formulation based on an association of glycogen and alginate |
| 07/09/2009 | WO2009083559A1 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 07/09/2009 | WO2009083553A1 Azine compounds as glucokinase activators |
| 07/09/2009 | WO2009083532A2 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof |
| 07/09/2009 | WO2009083526A1 Novel compounds |
| 07/09/2009 | WO2009083521A2 Antibacterial compositions comprising an antiseptic in combination with an antibiotic |
| 07/09/2009 | WO2009083520A2 Liquid oral florfenicol compositions which can be diluted in drinking water |
| 07/09/2009 | WO2009083444A1 Composition for the treatment of osteoarthritis |
| 07/09/2009 | WO2009083436A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/09/2009 | WO2009083272A2 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES |
| 07/09/2009 | WO2009083271A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083270A1 15,16-methylene-steroid-17,17-lactol derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083269A1 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE |
| 07/09/2009 | WO2009083268A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083267A2 Steroid-17,17-lactol derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083266A1 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE |
| 07/09/2009 | WO2009083253A1 Positive controls for expression modulating experiments |
| 07/09/2009 | WO2009083232A1 Parvovirus cancer therapy and combination with chemotherapy |
| 07/09/2009 | WO2009083177A1 TREATMENT OF HEART DISEASE USING β-BLOCKERS |
| 07/09/2009 | WO2009083169A1 Preparation comprising a creatine component, method for the production thereof, and the use thereof |
| 07/09/2009 | WO2009083155A1 Substance containing at least one active ingredient that has a gum-growing effect |
| 07/09/2009 | WO2009083115A1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
| 07/09/2009 | WO2009083076A1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 07/09/2009 | WO2009083042A1 Methods and means for the treatment of cancer |
| 07/09/2009 | WO2009082883A1 Antiobesity composition |
| 07/09/2009 | WO2009082881A1 Tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses thereof |
| 07/09/2009 | WO2009082819A1 Novel lupane derivatives |
| 07/09/2009 | WO2009082818A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | WO2009082817A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | WO2009082795A1 Derivatives of 4-nerolidylcatechol, pharmaceutical compositions comprising them and process for producing the same |
| 07/09/2009 | WO2009073586A8 Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels |
| 07/09/2009 | WO2009066955A3 Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same |
| 07/09/2009 | WO2009066138A3 Stabilization of vitamin b complex and lidocaine hydrochloride injection |
| 07/09/2009 | WO2009062874A3 Benzimidazole derivatives and their use as fxr agonists |
| 07/09/2009 | WO2009061924A3 Aldh-2 inhibitors in the treatment of psychiatric disorders |
| 07/09/2009 | WO2009058958A3 Lipoxin a4 protection for cornea endothelial cells |
| 07/09/2009 | WO2009057811A3 Heterocyclic compound and pharmaceutical composition thereof |
| 07/09/2009 | WO2009057795A3 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 07/09/2009 | WO2009056617A3 4,4-disubstituted piperdines as renin inhibitors |
| 07/09/2009 | WO2009048940A3 Diacerein pharmaceutical formulations |
| 07/09/2009 | WO2009048778A3 Laminins, derivatives, and compositions including same and method for their therapeutic use |
| 07/09/2009 | WO2009048590A3 Amino acid combinant omega oil aphrodisiac |
| 07/09/2009 | WO2009045908A4 A method for screening of prostaglandin compounds comprising an optimal formulation for the enhancement of hair growth and the stimulation of follicular anagen and formulations resulting therefrom |
| 07/09/2009 | WO2009042200A9 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 07/09/2009 | WO2009037705A3 Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation |
| 07/09/2009 | WO2009036368A3 Drug carriers |
| 07/09/2009 | WO2009034029A3 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
| 07/09/2009 | WO2009031051A3 Stabilized anthocyanin compositions |
| 07/09/2009 | WO2009024889A3 Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| 07/09/2009 | WO2009023509A3 Therapeutic combinations useful in treating cftr related diseases |